Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (unaudited)

v3.24.1.1.u2
Statements of Operations (unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 1,600,741 $ 1,192,633
General and administrative 1,602,819 1,085,049
Total operating expenses 3,203,560 2,277,682
Loss from operations (3,203,560) (2,277,682)
Other income and expenses:    
Interest income, net 69,298 37,540
Net loss $ (3,134,262) $ (2,240,142)
Net loss per share of common stock, basic and diluted $ (0.47) $ (2.27)
Weighted-average basic and diluted shares 6,660,840 985,848